BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong WJ, Liu J, Jiang JD. Human low-density lipoprotein receptor gene and its regulation. J Mol Med (Berl). 2006;84:29-36. [PMID: 16292665 DOI: 10.1007/s00109-005-0717-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Kong WJ, Vernieri C, Foiani M, Jiang JD. Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders. Pharmacol Ther 2020;209:107496. [PMID: 32001311 DOI: 10.1016/j.pharmthera.2020.107496] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
2 Wang YX, Wang YP, Zhang H, Kong WJ, Li YH, Liu F, Gao RM, Liu T, Jiang JD, Song DQ. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor. Bioorg Med Chem Lett 2009;19:6004-8. [PMID: 19800225 DOI: 10.1016/j.bmcl.2009.09.059] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
3 Bielinski SJ, Pankow JS, Foster CL, Miller MB, Hopkins PN, Eckfeldt JH, Hixson J, Liu Y, Register T, Myers RH, Arnett DK. Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: the NHLBI Family Heart Study follow-up examination. Atherosclerosis 2008;199:172-8. [PMID: 18045607 DOI: 10.1016/j.atherosclerosis.2007.10.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
4 Natesampillai S, Kerkvliet J, Leung PC, Veldhuis JD. Regulation of Kruppel-like factor 4, 9, and 13 genes and the steroidogenic genes LDLR, StAR, and CYP11A in ovarian granulosa cells. Am J Physiol Endocrinol Metab 2008;294:E385-91. [PMID: 18056793 DOI: 10.1152/ajpendo.00480.2007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
5 Mosig S, Rennert K, Büttner P, Krause S, Lütjohann D, Soufi M, Heller R, Funke H. Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism. BMC Med Genomics 2008;1:60. [PMID: 19040724 DOI: 10.1186/1755-8794-1-60] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
6 Jackson KG, Abraham EC, Smith AM, Murray P, O'Malley B, Williams CM, Minihane AM. Impact of age and menopausal status on the postprandial triacylglycerol response in healthy women. Atherosclerosis 2010;208:246-52. [PMID: 19640535 DOI: 10.1016/j.atherosclerosis.2009.06.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
7 Wang YX, Kong WJ, Li YH, Tang S, Li Z, Li YB, Shan YQ, Bi CW, Jiang JD, Song DQ. Synthesis and structure-activity relationship of berberine analogues in LDLR up-regulation and AMPK activation. Bioorg Med Chem 2012;20:6552-8. [PMID: 23058107 DOI: 10.1016/j.bmc.2012.09.029] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
8 Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism. 2009;58:109-119. [PMID: 19059538 DOI: 10.1016/j.metabol.2008.08.013] [Cited by in Crossref: 145] [Cited by in F6Publishing: 132] [Article Influence: 12.1] [Reference Citation Analysis]
9 Chung MJ, Kang AY, Park SO, Park KW, Jun HJ, Lee SJ. The effect of essential oils of dietary wormwood (Artemisia princeps), with and without added vitamin E, on oxidative stress and some genes involved in cholesterol metabolism. Food Chem Toxicol 2007;45:1400-9. [PMID: 17368686 DOI: 10.1016/j.fct.2007.01.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
10 Yan H, Ma YL, Gui YZ, Wang SM, Wang XB, Gao F, Wang YP. MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression. Acta Pharmacol Sin 2014;35:994-1004. [PMID: 25042549 DOI: 10.1038/aps.2014.52] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
11 Kong WJ, Wei J, Zuo ZY, Wang YM, Song DQ, You XF, Zhao LX, Pan HN, Jiang JD. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metabolism 2008;57:1029-37. [PMID: 18640378 DOI: 10.1016/j.metabol.2008.01.037] [Cited by in Crossref: 107] [Cited by in F6Publishing: 97] [Article Influence: 8.2] [Reference Citation Analysis]
12 Nechepurenko IV, Komarova NI, Shernyukov AV, Vasiliev VG, Salakhutdinov NF. Smiles rearrangements in a series of berberine analogues containing a secondary acetamide fragment. Tetrahedron Letters 2014;55:6125-7. [DOI: 10.1016/j.tetlet.2014.09.059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
13 Nechepurenko IV, Boyarskikh UA, Komarova NI, Polovinka MP, Filipenko ML, Lifshits GI, Salakhutdinov NF, Tolstikov GA. LDLR up-regulatory activity of berberine and its bromo and iodo derivatives in human liver HepG2 cells. Dokl Chem 2011;439:204-8. [DOI: 10.1134/s0012500811070093] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
14 Caliceti C, Rizzo P, Cicero AF. Potential benefits of berberine in the management of perimenopausal syndrome. Oxid Med Cell Longev 2015;2015:723093. [PMID: 25785174 DOI: 10.1155/2015/723093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
15 Poirier J, Cockell KA, Scoggan KA, Nimal Ratnayake WM, Rocheleau H, Gruber H, Swist E, Griffin P, Gagnon C, Kubow S. High-dose supplemental selenite to male Syrian hamsters fed hypercholesterolaemic diets alters Ldlr , Abcg8 and Npc1l1 mRNA expression and lowers plasma cholesterol concentrations. Br J Nutr 2012;108:257-66. [DOI: 10.1017/s0007114511005587] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Daimiel L, Vargas T, Ramírez de Molina A. Nutritional genomics for the characterization of the effect of bioactive molecules in lipid metabolism and related pathways. Electrophoresis 2012;33:2266-89. [PMID: 22887150 DOI: 10.1002/elps.201200084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
17 Yamamoto T, Harada-Shiba M, Nakatani M, Wada S, Yasuhara H, Narukawa K, Sasaki K, Shibata MA, Torigoe H, Yamaoka T, Imanishi T, Obika S. Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice. Mol Ther Nucleic Acids 2012;1:e22. [PMID: 23344002 DOI: 10.1038/mtna.2012.16] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
18 Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ, Wang SK, Zhou ZX, Song DQ, Wang YM. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010;59:285-292. [PMID: 19800084 DOI: 10.1016/j.metabol.2009.07.029] [Cited by in Crossref: 245] [Cited by in F6Publishing: 227] [Article Influence: 20.4] [Reference Citation Analysis]
19 Bermudez B, Lopez S, Varela LM, Ortega A, Pacheco YM, Moreda W, Moreno-luna R, Abia R, Muriana FJG. Triglyceride-Rich Lipoprotein Regulates APOB48 Receptor Gene Expression in Human THP-1 Monocytes and Macrophages. The Journal of Nutrition 2012;142:227-32. [DOI: 10.3945/jn.111.149963] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
20 Li YH, Yang P, Kong WJ, Wang YX, Hu CQ, Zuo ZY, Wang YM, Gao H, Gao LM, Feng YC, Du NN, Liu Y, Song DQ, Jiang JD. Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy. J Med Chem 2009;52:492-501. [PMID: 19090767 DOI: 10.1021/jm801157z] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
21 Aroor AR, Shukla SD. Binge ethanol intake in chronically exposed rat liver decreases LDL-receptor and increases angiotensinogen gene expression. World J Hepatol 2011; 3(9): 250-255 [PMID: 21969878 DOI: 10.4254/wjh.v3.i9.250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
22 Cicero AF, Baggioni A. Berberine and Its Role in Chronic Disease. Adv Exp Med Biol 2016;928:27-45. [PMID: 27671811 DOI: 10.1007/978-3-319-41334-1_2] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 19.3] [Reference Citation Analysis]
23 Yamamoto T, Ryan RO. Domain swapping reveals that low density lipoprotein (LDL) type A repeat order affects ligand binding to the LDL receptor. J Biol Chem 2009;284:13396-400. [PMID: 19329437 DOI: 10.1074/jbc.M900194200] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
24 Pang B, Zhao LH, Zhou Q, Zhao TY, Wang H, Gu CJ, Tong XL. Application of berberine on treating type 2 diabetes mellitus. Int J Endocrinol. 2015;2015:905749. [PMID: 25861268 DOI: 10.1155/2015/905749] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 15.2] [Reference Citation Analysis]
25 Cao S, Xu P, Yan J, Liu H, Liu L, Cheng L, Qiu F, Kang N. Berberrubine and its analog, hydroxypropyl‐berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exert cholesterol‐lowering effects in human hepatoma HepG2 cells. J Cell Biochem 2019;120:1340-9. [DOI: 10.1002/jcb.27102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
26 Soutar AK. Regulation of the LDL receptor in familial hypercholesterolemia. Clinical Lipidology 2009;4:755-65. [DOI: 10.2217/clp.09.60] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Gouni-Berthold I, Berthold HK, Gylling H, Hallikainen M, Giannakidou E, Stier S, Ko Y, Patel D, Soutar AK, Seedorf U, Mantzoros CS, Plat J, Krone W. Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men. Atherosclerosis 2008;198:198-207. [PMID: 17980884 DOI: 10.1016/j.atherosclerosis.2007.09.034] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
28 Jacobs F, Van Craeyveld E, Feng Y, Snoeys J, De Geest B. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia. Atherosclerosis 2008;201:289-97. [PMID: 18378244 DOI: 10.1016/j.atherosclerosis.2008.02.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
29 Aroor AR, Jackson DE, Shukla SD. Dysregulated phosphorylation and nuclear translocation of cyclic AMP response element binding protein (CREB) in rat liver after chronic ethanol binge. Eur J Pharmacol 2012;679:101-8. [PMID: 22269225 DOI: 10.1016/j.ejphar.2011.12.045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
30 Vargas NB, Brewer BY, Rogers TB, Wilson GM. Protein kinase C activation stabilizes LDL receptor mRNA via the JNK pathway in HepG2 cells. J Lipid Res 2009;50:386-97. [PMID: 18936517 DOI: 10.1194/jlr.M800316-JLR200] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
31 Wang D, Yang X, Chen Y, Gong K, Yu M, Gao Y, Wu X, Hu H, Liao C, Han J, Duan Y. Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression. J Biol Chem 2020;295:15870-82. [PMID: 32913121 DOI: 10.1074/jbc.RA120.015623] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Li YH, Li Y, Yang P, Kong WJ, You XF, Ren G, Deng HB, Wang YM, Wang YX, Jiang JD, Song DQ. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine. Bioorg Med Chem 2010;18:6422-8. [PMID: 20673726 DOI: 10.1016/j.bmc.2010.06.106] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
33 Krebs J, Heizmann CW. Calcium-binding proteins and the EF-hand principle. Calcium - A Matter of Life or Death. Elsevier; 2007. pp. 51-93. [DOI: 10.1016/s0167-7306(06)41003-6] [Cited by in Crossref: 16] [Article Influence: 1.1] [Reference Citation Analysis]
34 Shan YQ, Ren G, Wang YX, Pang J, Zhao ZY, Yao J, You XF, Si SY, Song DQ, Kong WJ, Jiang JD. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux. Metabolism 2013;62:446-56. [PMID: 23079743 DOI: 10.1016/j.metabol.2012.09.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
35 Xiong Q, Lin M, Rikihisa Y. Cholesterol-dependent anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway. PLoS Pathog 2009;5:e1000329. [PMID: 19283084 DOI: 10.1371/journal.ppat.1000329] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]